Skip to main navigation
logo

Investor Relations

  • Investor Overview
  • Stock Information
    • Stock Quote & Chart
  • News & Events
    • News Releases
    • Events
  • SEC Filings
  • Corporate Governance
    • Governance Documents
    • Management Team
    • Board of Directors
    • Committee Composition
  • Investor Resources
    • Corporate Presentation
    • Investor FAQs
    • Email Alerts
    • Contact IR

News Releases

News Releases

12 May '20
Black Diamond Therapeutics Reports First Quarter 2020 Financial Results and Corporate Update
06 May '20
Black Diamond Therapeutics to Present at the Bank of America Global Research Health Care Conference 2020
24 Mar '20
Black Diamond Therapeutics Reports Fourth Quarter and Full Year 2019 Financial Results and Corporate Update
24 Feb '20
Black Diamond Therapeutics to Present at the Cowen and Company 40th Annual Health Care Conference
03 Feb '20
Black Diamond Therapeutics Announces Closing of Initial Public Offering and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares
29 Jan '20
Black Diamond Therapeutics Announces Pricing of Initial Public Offering
05 Dec '19
Black Diamond Therapeutics Closes $85 Million Series C Financing
26 Sep '19
Black Diamond Therapeutics to Present Preclinical Data on its Lead Product Candidate BDTX-189 at the European Society for Medical Oncology 2019
19 Sep '19
Black Diamond Therapeutics Names Christopher Roberts, Ph.D., as Chief Scientific Officer
12 Sep '19
Black Diamond Therapeutics Appoints Thomas Leggett as Chief Financial Officer

Pagination

  • First page « first
  • Previous page ‹ previous
  • Page 1
  • Page 2
  • Current page 3
  • Page 4
  • Next page next ›
  • Last page last »
Displaying 21 - 30 of 34

Investor Tools

  • Print Page
  • E-mail Alerts
  • RSS Feeds
footer-logo

Footer Links

ABOUT US
TECHNOLOGY
PIPELINE
NEWS
CAREERS
CONTACT

© 2021 Black Diamond Therapeutics, Inc.     All rights reserved.

  • Facebook
  • Twitter
  • LinkedIn
  • Google+